We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blood Tests for Inflammation Can Be Discordant

By LabMedica International staff writers
Posted on 30 Oct 2012
Print article
The erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels are widely used tests of inflammation that sometimes show opposite results.

However, CRP and ESR may not correlate substantially in some conditions, and the extent to which CRP and ESR results agree with each other in an unselected patient population is not clear in clinical practice, as the results of the two tests are sometimes different.

Scientists at the Texas Health Presbyterian Hospital (Dallas, TX, USA) performed 2,150 paired CRP/ESR measurements in 1,753 patients, between January and December of 2011. There were 1,731 patients who were not pregnant and were all adults aged 18 years or more. Initial CRP and ESR results for each patient were divided into quartiles.

The CRP assay performed is based on a reaction between CRP in a serum or plasma sample and polyclonal anti-CRP antibodies that have been adsorbed to latex particles the Multigent CRP Vario Reagent, (Sentinel; Milan, Italy). Agglutination is detected as an absorbance change at 572 nm on the Architect c8000 (Abbott Laboratories; Abbott Park, IL, USA). The ESR assay samples are read with an ESR-Auto Plus instrument in QuickMode (Streck; Omaha, NE, USA) and converted to Westergren units. The results can range from zero to greater than 120 mm/hour.

The ages of the 105 patients in the high CRP/low ESR–discordant group and the 107 in the high ESR/low CRP–discordant group were similar. The high CRP/low ESR–discordant group had more patients with infections than the high ESR/low CRP–discordant group particularly infections in the urinary tract, gastrointestinal tract, lungs and bloodstream. However, they had fewer bone and joint infections than the high ESR/low CRP–discordant group.

Connective tissue diseases, such as systemic lupus erythematosus, were less common in the high CRP/low ESR–discordant group than in the high ESR/low CRP–discordant group. Ischemic strokes or transient ischemic attacks almost invariably occurred in the high ESR/low CRP–discordant group, whereas myocardial infarction or venous thromboembolism was limited to the high CRP/low ESR–discordant group. The authors concluded that their findings will provide information to physicians who order these two tests together and receive discordant results, which occurs in approximately one in eight patients. The study was published on August 23, 2012, in the journal Translational Research.

Related Links:

Texas Health Presbyterian Hospital
Sentinel
Abbott Laboratories


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TORCH Infections Test
TORCH Panel
New
Immunofluorescence Analyzer
MPQuanti

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.